Filter
4387
Filtered Results: 4387
Text search:
drug
therapy
Featured
Recommendations
404
New Publications
1133
Language
Document type
No document type
2797
Studies & Reports
589
Guidelines
572
Manuals
162
Strategic & Response Plan
95
Fact sheets
70
Training Material
51
Situation Updates
20
Infographics
13
Resource Platforms
9
Brochures
6
Online Courses
2
App
1
Countries / Regions
India
290
Kenya
124
Global
119
South Africa
114
Uganda
98
Ethiopia
97
Western and Central Europe
94
Nigeria
82
Tanzania
79
Nepal
77
Zambia
76
Sierra Leone
62
Malawi
62
Africa
59
Eastern Europe
58
Liberia
55
Ukraine
53
Ghana
52
Latin America and the Carribbean
52
Rwanda
50
Myanmar / Burma
50
Bangladesh
41
Namibia
41
Zimbabwe
38
Russia
37
Asia
36
Indonesia
35
Lesotho
33
Philippines
32
Cambodia
28
South–East Asia Region
23
Botswana
20
Senegal
18
Germany
17
Syria
17
Eswatini/ Swaziland
16
East and Southern Africa
15
Burkina Faso
14
Mozambique
14
USA
13
West and Central Africa
13
Middle East and North Africa
13
Cameroon
11
Brazil
11
Albania
11
Congo, Democratic Republic of
10
Haiti
10
South Sudan
10
Colombia
10
Tajikistan
10
Eastern Europe and Central Asia
9
Venezuela
8
Pakistan
7
Thailand
7
Sudan
7
Benin
6
Argentina
6
Western Pacific Region
6
Georgia
6
Iraq
5
Afghanistan
5
China
5
Peru
5
Armenia
5
Guinea
4
North Macedonia
4
Bolivia
4
Yemen
4
Paraguay
4
Bhutan
4
Moldova
4
Vietnam
4
United Kingdom
4
Spain
4
Somalia
3
Jordan
3
Sri Lanka
3
Laos
3
Timor Leste/ East Timor
3
Estonia
3
Jamaica
3
Saudi Arabia
2
Lebanon
2
Turkey
2
Papua New Guinea
2
Central African Republic
2
Switzerland
2
Angola
2
Fiji
2
Poland
2
Southern Africa
2
Canada
2
Iran
2
Kyrgyzstan
2
Kazakhstan
2
North America
2
Gabon
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Chad
1
Gambia
1
Malaysia
1
Ireland
1
Singapore
1
Austria
1
Serbia
1
Hungary
1
Ecuador
1
Greece
1
Libya
1
Madagascar
1
Mexico
1
Chile
1
Solomon Islands
1
Palestine
1
North Korea
1
Mongolia
1
Qatar
1
Bulgaria
1
Romania
1
Lithuania
1
Uzbekistan
1
Australia
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
1673
Clinical Guidelines
469
Public Health
202
Women & Child Health
151
Capacity Building
59
Key Resources
55
Pharmacy & Technologies
47
Toolboxes
HIV
642
TB
481
Mental Health
441
AMR
224
COVID-19
150
Pharmacy
150
NTDs
142
NCDs
105
Caregiver
77
Rapid Response
57
Ebola
55
Refugee
46
Conflict
42
Disability
41
Planetary Health
29
Global Health Education
26
Polio
16
Health Financing Toolbox
15
Cholera
13
Specific Hazards
11
Natural Hazards
10
Zika
9
Social Ethics
6
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread ... resistance in HAT patients where the genetic mechanism has been established.
The current goal of elimination of HAT as a public health problem by 2020 may be undermined by the emergence and spread of resistance to current or new drugs.
Insights into potential resistance mechanisms for current and new drugs will facilitate predictions of the likelihood of resistance and will also facilitate rational approaches to minimizing, monitoring, and tackling the future emergence of resistance.
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexualit...
Factors to take into account when choosing, reviewing and changing medicines.
Rescue therapy:
For symptomatic hyperglycaemia, consider insulin or a sulfonylurea and review when blood glucose control has been achieved.
Diet and lifestyle advice:
...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
Q11: 11a). In women with epilepsy, should antiepileptic therapy be prescribed as monotherapy or polytherapy to decrease the risk of fetal malformations?
11b). Does the use of folic acid preconceptually decrease the risk of foetal malformations in w...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a ...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Prevention of stroke and transient ischemic attack includes both conventional approaches to vascular risk factor management (blood pressure lowering, cholesterol reduction with statins, smoking cessation and antiplatelet therapy)
and more specific ...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-... interaction panel and now consists of six main sections, including a general overview table of all major issues in PLWH, recommendations on antiretroviral treatment, drug-drug interactions, diagnosis, monitoring and treatment of co-morbidities, co-infections and opportunistic diseases.
Available in English, French, Spanish, German, Portuguese, Russian, Chinese and Japanese
This manual provides practical guidelines for the management of children with severe malnutrition. It seeks to promote the best available therapy so as to reduce the risk of death, shorten the length of time spent in hospital, and facilitate rehabil...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resis...
Antimicrobial Resistance Surveillance and Research Network | This manual describes well accepted methods to carry out drug susceptibility testing on important gram positive and gram negative clinically relevant bacteria. Methods of specimen collecti...
People living with HIV who have a low CD4 count are at a much higher risk of falling ill from TB infection than HIV negative people.
It is important to offer both HIV testing to TB patients and TB diagnosis in HIV patients. Early detection and effective treatment are essential to preventing TB...
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to inves...
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with ...
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International ... Monitoring. This text was developed in consultation with the WHO Collaborating Centre for International Drug Monitoring and the national pharmacovigilance centres participating in the WHO Programme for International Drug Monitoring.
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate ...
